Humana Inc.
Humana Inc. Reports First Quarter 2025 Financial Results and Revises Earnings Guidance
Summary
Humana Inc. reported consolidated pretax results and net earnings per share (EPS) for the quarter ended March 31, 2025, showing an earnings per share (EPS) of $10.30 on a GAAP basis and $11.58 on an Adjusted basis. The company affirmed its Adjusted FY 2025 EPS guidance of approximately $16.25 while revising its GAAP EPS guidance to approximately $14.68. The insurance segment's benefit ratio for 1Q25 was 87.4 percent, and the company remains confident in its pricing strategy. Humana also provided updates on its long-term strategy with achievements in its CenterWell and Medicaid businesses.
Get alerts for HUM
Be first to know when Humana Inc. files with the SEC.
Filing Categories
Exhibits (3)
Advertisement
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Official SEC Documents
Advertisement